Related Experiment Videos
Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis
B A Michel1, W P Arend, G G Hunder
1Clinic of Rheumatology, University Hospital, Zürich, Switzerland.
The Journal of Rheumatology
|January 1, 1996
Summary
Giant cell arteritis (GCA) and Takayasu
Area of Science:
- Rheumatology
- Vascular Medicine
- Immunology
Background:
- Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are large-vessel vasculitides.
- Distinguishing between GCA and TA can be challenging due to overlapping clinical features.
Purpose of the Study:
- To differentiate GCA from TA using clinical findings.
- To identify key clinical variables that distinguish these two vasculitic disorders.
Main Methods:
- Comparative study of 217 GCA patients and 63 TA patients.
- Utilized the American College of Rheumatology Vasculitis Criteria Databank.
- Employed logistic regression and recursive partitioning for analysis.
Main Results:
- Age at onset >40 years was the most significant single differentiating variable.
- Excluding age, a combination of ethnic background, upper limb vascular impairment, shoulder stiffness, and tender scalp achieved 95% correct classification.
- Upper extremity vascular insufficiency occurred in 15% of GCA patients.
Conclusions:
- GCA and TA are distinct and easily separable vasculitic disorders.
- Clinical findings, beyond the typical age of onset, effectively differentiate GCA and TA.
- These findings support the classification of GCA and TA as separate disease entities.